Srimoyee Ghosh

Srimoyee Ghosh is a seasoned professional in the field of oncology and immuno-oncology, currently serving as Senior Director of Oncology External Innovation at Ipsen since June 2024. Prior to this role, Srimoyee held the position of Director of Oncology Biomarkers in Precision Medicine at GSK from January 2019 to May 2024, focusing on immuno-oncology clinical biomarker strategy and research. Experience also includes serving as Principal Scientist in Immuno-oncology at TESARO from March 2016 to December 2018 and as Senior Scientist I at Constellation Pharmaceuticals from February 2012 to March 2016, with a background in exploring epigenetic targets in cancer immunotherapy. Earlier roles include Scientist II and Scientist, contributing to research on cancer immunotherapy and inflammation, and a brief tenure as a Research Scientist at the Broad Institute. Srimoyee Ghosh holds a B.Sc. (Hons) in Biochemistry from Delhi University and further education from Jawaharlal Nehru University.